A Patient Power Team Member's Clinical Trial Video Diary: Month 2

Published on

Topics include: Patient Stories

Patient Power contributor Michele Nadeem, on location at the Dana-Faber Cancer Institute, shares a video health update as she enters month two of the clinical trial she is participating in, which combines ibrutinib (Imbuvica) with FCR (fludarabine, cyclophosphamide, rituximab). Michele reviews the side effects she has experienced since beginning the trial and why she feels the progress she has seen is “truly a miracle.”

View more programs featuring

Related Programs

A Patient Power Team Member Shares Her Clinical Trial Experience

Patient Power contributor and CLL patient Michele Nadeem-Baker shares the first of a series of personal video blogs as she reports on her progress in a CLL clinical trial at the Dana-Farber Cancer Institute in Boston, Mass.


Join Our Community Register for Events Read Our Latest Blog

Page last updated on July 29, 2016